These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


325 related items for PubMed ID: 31645430

  • 21. Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.
    Tu JJ, Kumar A, Giorgi EE, Eudailey J, LaBranche CC, Martinez DR, Fouda GG, Moreau Y, Thomas A, Montefiori D, Gao F, Sagar M, Permar SR.
    J Virol; 2022 Jun 08; 96(11):e0023122. PubMed ID: 35536018
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand.
    Wieczorek L, Peachman K, Adams DJ, Barrows B, Molnar S, Schoen J, Dawson P, Bryant C, Chenine AL, Sanders-Buell E, Srithanaviboonchai K, Pathipvanich P, Michael NL, Robb ML, Tovanabutra S, Rao M, Polonis VR.
    Virology; 2020 Sep 08; 548():152-159. PubMed ID: 32838936
    [Abstract] [Full Text] [Related]

  • 23. Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers.
    Kumar A, Giorgi EE, Tu JJ, Martinez DR, Eudailey J, Mengual M, Honnayakanahalli Marichannegowda M, Van Dyke R, Gao F, Permar SR.
    PLoS Pathog; 2021 Apr 08; 17(4):e1009478. PubMed ID: 33798244
    [Abstract] [Full Text] [Related]

  • 24. Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions.
    Van de Perre P, Goga A, Ngandu N, Nagot N, Moodley D, King R, Molès JP, Mosqueira B, Chirinda W, Scarlatti G, Tylleskär T, Dabis F, Gray G.
    Lancet; 2021 Apr 03; 397(10281):1316-1324. PubMed ID: 33812490
    [Abstract] [Full Text] [Related]

  • 25. Pre-existing infant antibody-dependent cellular cytotoxicity associates with reduced HIV-1 acquisition and lower morbidity.
    Thomas AS, Moreau Y, Jiang W, Isaac JE, Ewing A, White LF, Kourtis AP, Sagar M.
    Cell Rep Med; 2021 Oct 19; 2(10):100412. PubMed ID: 34755132
    [Abstract] [Full Text] [Related]

  • 26. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
    Tippett Barr BA, van Lettow M, van Oosterhout JJ, Landes M, Shiraishi RW, Amene E, Schouten E, Wadonda-Kabondo N, Gupta S, Auld AF, Kalua T, Jahn A.
    Lancet HIV; 2018 Dec 19; 5(12):e688-e695. PubMed ID: 30467022
    [Abstract] [Full Text] [Related]

  • 27. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    Kesho Bora Study Group, de Vincenzi I.
    Lancet Infect Dis; 2011 Mar 19; 11(3):171-80. PubMed ID: 21237718
    [Abstract] [Full Text] [Related]

  • 28. HIV transmission through breastfeeding: problems and prevention.
    Ogundele MO, Coulter JB.
    Ann Trop Paediatr; 2003 Jun 19; 23(2):91-106. PubMed ID: 12803739
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Predictors of Perinatal HIV Transmission Among Women Without Prior Antiretroviral Therapy in a Resource-Limited Setting: The Breastfeeding, Antiretrovirals and Nutrition Study.
    Ewing AC, Ellington SR, Wiener JB, Chasela CS, Tegha G, Nelson JAE, Jamieson DJ, van der Horst C, Kourtis AP, BAN Study Team.
    Pediatr Infect Dis J; 2019 May 19; 38(5):508-512. PubMed ID: 30985546
    [Abstract] [Full Text] [Related]

  • 31. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.
    Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394
    [Abstract] [Full Text] [Related]

  • 32. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
    Zeh C, Weidle PJ, Nafisa L, Lwamba HM, Okonji J, Anyango E, Bondo P, Masaba R, Fowler MG, Nkengasong JN, Thigpen MC, Thomas T.
    PLoS Med; 2011 Mar 06; 8(3):e1000430. PubMed ID: 21468304
    [Abstract] [Full Text] [Related]

  • 33. Antiretroviral drugs to prevent mother-to-child transmission of HIV during breastfeeding.
    Shetty AK, Maldonado Y.
    Curr HIV Res; 2013 Mar 06; 11(2):102-25. PubMed ID: 23432487
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Towards elimination of mother-to-child transmission of HIV in Rwanda: a nested case-control study of risk factors for transmission.
    Remera E, Mugwaneza P, Chammartin F, Mulindabigwi A, Musengimana G, Forrest JI, Mwanyumba F, Kondwani N, Condo JU, Riedel DJ, Mills EJ, Nsanzimana S, Bucher HC.
    BMC Pregnancy Childbirth; 2021 Apr 28; 21(1):339. PubMed ID: 33910502
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD003510. PubMed ID: 17253490
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.